P-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 7, 2015, Pages 1520-1530

  García, Raquel ^a,b   Nistal, J Francisco ^b   Merino, David ^a,b   Price, Nathan L ^c   Fernández Hernando, Carlos ^c   Beaumont, Javier ^d   González, Arantxa ^d   Hurlé, María A ^a,b   Villar, Ana V ^a,b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

DICER; Myocardial fibrosis; P SMAD2 3; Pre miR 21; Pressure overload; TGF

Indexed keywords

DICER; MESSENGER RNA; MICRORNA 21; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; DEAD-BOX RNA HELICASES; DICER1 PROTEIN, MOUSE; MICRORNAS; MIRN21 MICRORNA, MOUSE; PROTEIN BINDING; RIBONUCLEASE III; SMAD2 PROTEIN, MOUSE; SMAD3 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMAL EXPERIMENT; AORTA CONSTRICTION; AORTA STENOSIS; ARTICLE; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA PROCESSING; UPREGULATION; WESTERN BLOTTING; 3T3 CELLS; ANIMALS; AORTIC VALVE STENOSIS; CELLS, CULTURED; DRUG EFFECTS; GENETICS; HUMANS; METABOLISM; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; RNA PROCESSING, POST-TRANSCRIPTIONAL; VENTRICULAR REMODELING;

MUS;

3T3 CELLS; ANIMALS; AORTIC VALVE STENOSIS; CELLS, CULTURED; DEAD-BOX RNA HELICASES; HUMANS; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCYTES, CARDIAC; PROTEIN BINDING; RIBONUCLEASE III; RNA PROCESSING, POST-TRANSCRIPTIONAL; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR REMODELING;

EID: 84928599266     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.04.006     Document Type: Article

References (39)

1. Hill J.A., Olson E.N. Cardiac plasticity. N. Engl. J. Med. 2008, 358:1370-1380. 10.1056/NEJMra072139.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5.
3. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Rådmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419. 10.1038/nature01957.
4. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240. 10.1038/nature03049.
5. Kawai S., Amano A. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. J. Cell Biol. 2012, 197:201-208. 10.1083/jcb.201110008.
6. Park J.E., Heo I., Tian Y., Simanshu D.K., Chang H., Jee D., Patel D.J., Kim V.N. Dicer recognizes the 5' end of RNA for efficient and accurate processing. Nature 2011, 475:201-205. 10.1038/nature10198.
7. Kok K.H., Ng M.H., Ching Y.P., Jin D.Y. Human TRBP and PACT directly interact with each other and associate with Dicer to facilitate the production of small interfering RNA. J. Biol. Chem. 2007, 282:17649-17657. (doi:rna.283207[pii].10.1261/rna.283207).
8. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744. 10.1038/nature03868.
9. Kawamata T., Tomari Y. Making RISC. Trends Biochem. Sci. 2010, 35:368-376. 10.1016/j.tibs.2010.03.009.
10. van Rooij E., Purcell A.L., Levin A.A. Developing microRNA therapeutics. Circ. Res. 2012, 110:496-507. 10.1161/CIRCRESAHA.111.247916.
11. Dangwal S., Thum T. microRNA therapeutics in cardiovascular disease models. Annu. Rev. Pharmacol. Toxicol. 2014, 54:185-203. 10.1146/annurev-pharmtox-011613-135957.
12. Condorelli G., Latronico M.V., Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J. Am. Coll. Cardiol. 2014, 63:2177-2187. 10.1016/j.jacc.2014.01.050.
13. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M.A., Licht J.D., Pena J.T., Rouhanifard S.H., Muckenthaler M.U., Tuschl T., Martin G.R., Bauersachs J., Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984. 10.1038/nature07511.
14. Tijsen A.J., Pinto Y.M., Creemers E.E. Non-cardiomyocyte microRNAs in heart failure. Cardiovasc. Res. 2012, 93:573-582. 10.1093/cvr/cvr344.
15. Villar A.V., García R., Llano M., Cobo M., Merino D., Lantero A., Tramullas M., Hurlé J.M., Hurlé M.A., Nistal J.F. BAMBI (BMP and activin membrane-bound inhibitor) protects the murine heart from pressure-overload biomechanical stress by restraining TGF-β signaling. Biochim. Biophys. Acta Mol. Basis Dis. 2013, 1832:323-335. 10.1016/j.bbadis.2012.11.007.
16. Bang C., Batkai S., Dangwal S., Gupta S.K., Foinquinos A., Holzmann A., Just A., Remke J., Zimmer K., Zeug A., Ponimaskin E., Schmiedl A., Yin X., Mayr M., Halder R., Fischer A., Engelhardt S., Wei Y., Schober A., Fiedler J., Thum T. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 2014, 124:2136-2146. 10.1172/JCI70577.
17. Dobaczewski M., Chen W., Frangogiannis N.G. Transforming growth factor (TGF)-β signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 2011, 51:600-606. 10.1016/j.yjmcc.2010.10.033.
18. Creemers E.E., Pinto Y.M. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc. Res. 2011, 89:265-272. 10.1093/cvr/cvq308.
19. Liu G., Friggeri A., Yang Y., Milosevic J., Ding Q., Thannickal V.J., Kaminski N., Abraham E. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 2010, 207:1589-1597. 10.1084/jem.20100035.
20. Zhong X., Chung A.C., Chen H.Y., Meng X.M., Lan H.Y. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J. Am. Soc. Nephrol. 2011, 22:1668-1681. 10.1681/ASN.2010111168.
21. Zhu H., Luo H., Li Y., Zhou Y., Zhou Y., Jiang Y., Chai J., Xiao X., You Y., Zuo X. MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression. J. Clin. Immunol. 2013, 33:1100-1109. 10.1007/s10875-013-9896-z.
22. Villar A.V., García R., Merino D., Llano M., Cobo M., Montalvo C., Martín-Durán R., Hurlé M.A., Nistal J.F. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int. J. Cardiol. 2013, 167:2875-2878. 10.1016/j.ijcard.2012.07.021.
23. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61. 10.1038/nature07086.
24. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell 2010, 39:373-384. 10.1016/j.molcel.2010.07.011.
25. Davis-Dusenbery B.N., Hata A. Smad-mediated miRNA processing: a critical role for a conserved RNA sequence. RNA Biol. 2011, 8:71-76. 10.4161/rna.8.1.14299.
26. Söderberg O., Gullberg M., Jarvius M., Ridderstråle K., Leuchowius K.J., Jarvius J., Wester K., Hydbring P., Bahram F., Larsson L.G., Landegren U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 2006, 3:995-1000. 10.1038/nmeth947.
27. Söderberg O., Leuchowius K.J., Gullberg M., Jarvius M., Weibrecht I., Larsson L.G., Landegren U. Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 2008, 45:227-232. 10.1016/j.ymeth.2008.06.014.
28. Dangwal S., Bang C., Thum T. Novel techniques and targets in cardiovascular microRNA research. Cardiovasc. Res. 2012, 93:545-554. 10.1093/cvr/cvr297.
29. Glantz S.A., Slinker B.K. Primer of Applied Regression and Analysis of Variance 2000, McGraw-Hill, New York. 2nd ed.
30. Blahna M.T., Hata A. Regulation of miRNA biogenesis as an integrated component of growth factor signaling. Curr. Opin. Cell Biol. 2013, 25:233-242. 10.1016/j.ceb.2012.12.005.
31. Stalder L., Heusermann W., Sokol L., Trojer D., Wirz J., Hean J., Fritzsche A., Aeschimann F., Pfanzagl V., Basselet P., Weiler J., Hintersteiner M., Morrissey D.V., Meisner-Kober N.C. The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing. EMBO J. 2013, 32:1115-1127. 10.1038/emboj.2013.52.
32. Hoffer P., Ivashuta S., Pontes O., Vitins A., Pikaard C., Mroczka A., Wagner N., Voelker T. Posttranscriptional gene silencing in nuclei. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:409-414. 10.1073/pnas.1009805108.
33. Redfern A.D., Colley S.M., Beveridge D.J., Ikeda N., Epis M.R., Li X., Foulds C.E., Stuart L.M., Barker A., Russell V.J., Ramsay K., Kobelke S.J., Li X., Hatchell E.C., Payne C., Giles K.M., Messineo A., Gatignol A., Lanz R.B., O'Malley B.W., Leedman P.J. RNA-induced silencing complex (RISC) proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:6536-6541. 10.1073/pnas.1301620110.
34. Newman M.A., Hammond S.M. Emerging paradigms of regulated microRNA processing. Genes Dev. 2010, 24:1086-1092. 10.1101/gad.1919710.
35. Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 2010, 38:323-332. 10.1016/j.molcel.2010.03.013.
36. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610. 10.1038/nrg2843.
37. Kawahara Y., Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:3347-3352. 10.1073/pnas.1112427109.
38. Wei L.H., Huang X.R., Zhang Y., Li Y.Q., Chen H.Y., Heuchel R., Yan B.P., Yu C.M., Lan H.Y. Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension. PLoS One 2013, 8:e70195. 10.1371/journal.pone.0070195.
39. Kassiri Z., Oudit G.Y., Sanchez O., Dawood F., Mohammed F.F., Nuttall R.K., Edwards D.R., Liu P.P., Backx P.H., Khokha R. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ. Res. 2005, 19:380-390. 10.1161/01.RES.0000178789.16929.cf.